Lundbeck
HLUN-B.CO
₹364.51
Share price
-0.43%
Change (1 day)
-10.66%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Lundbeck (HLUN-B.CO) - P/B ratio
P/B ratio as of April 2025 : 1.18
According to Lundbeck
's latest financial reports the company has a price-to-book ratio of 1.29054.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lundbeck - P/B ratio (from 2009 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 1.60 | 10.85% |
| 2023-12-31 | 1.44 | 19.29% |
| 2022-12-31 | 1.21 | 389.39% |
| 2021-12-31 | 0.2468 | -24.87% |
| 2020-12-31 | 0.3285 | -18.51% |
| 2019-12-31 | 0.4031 | -24.37% |
| 2018-12-31 | 0.5330 | -22.52% |
| 2017-12-31 | 0.6880 | -12.94% |
| 2016-12-31 | 0.7902 | 11.56% |
| 2015-12-31 | 0.7083 | 195.88% |
| 2014-12-31 | 0.2394 | -10.42% |
| 2013-12-31 | 0.2673 | 61.86% |
| 2012-12-31 | 0.1651 | |
| 2011-12-31 | N/A | -100% |
| 2010-12-31 | 0.2504 | -13.54% |
| 2009-12-31 | 0.2896 |